[Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996]
- PMID: 9780478
[Efficacy of vigabatrin associated with carbamazepine in the treatment of epilepsy. Follow up 1993-1996]
Abstract
Purpose: To verify tolerance and clinical efficacy of vigabatrin (VGB), a new antiepileptic drug, in an add-on therapy with carbamazepine (CBZ).
Patients and methods: From september 1993 to december 1996, 35 patients with partial complex seizures (CPC) and CPC plus secondary generalization were treated, with VGB plus CBZ, VGB dose was 1.41 +/- 0.26 (g/die +/- SD) and CBZ 2.28 +/- 0.60 (g/die +/- SD).
Results: Patients were followed-up every 4 months showing an improvement between 61.5% and 68.8% from baseline.
Conclusions: In all patients we observed an improvement during the follow-up period. Side effects were mild and well tolerated.
Similar articles
-
[Therapeutic failure, treatment and non-treatment of childhood epilepsy].Rev Neurol. 1998 Sep;27(157):467-72. Rev Neurol. 1998. PMID: 9774821 Clinical Trial. Spanish.
-
[Vigabatrin: results with a new antiepileptic agents in 57 patients in a general neurological practice].Ned Tijdschr Geneeskd. 1994 Sep 10;138(37):1859-63. Ned Tijdschr Geneeskd. 1994. PMID: 7935922 Clinical Trial. Dutch.
-
Vigabatrin vs. carbamazepine monotherapy in newly diagnosed focal epilepsy: a randomized response conditional cross-over study.Epilepsy Res. 1996 Nov;25(3):257-62. doi: 10.1016/s0920-1211(96)00074-5. Epilepsy Res. 1996. PMID: 8956924 Clinical Trial.
-
[Vigabatrin and alterations of the visual field].Rev Neurol. 1999 Apr 16-30;28(8):741-5. Rev Neurol. 1999. PMID: 10363313 Review. Spanish.
-
Vigabatrin.Pediatr Nurs. 1998 Jul-Aug;24(4):357-61. Pediatr Nurs. 1998. PMID: 9849270 Review. No abstract available.